CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $12
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Otsuka Holdings Co (OtherOTSKF) and AngioDynamics (ANGO)
Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $13
AngioDynamics Is Maintained at Buy by Canaccord Genuity
AngioDynamics Price Target Cut to $12.00/Share From $13.00 by Canaccord Genuity
AngioDynamics Analyst Ratings
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14
AngioDynamics (ANGO) Gets a Buy From H.C. Wainwright
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $12
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14
AngioDynamics Analyst Ratings
Buy Rating Affirmed for AngioDynamics Following Positive Trial Outcomes and Market Expansion Potential
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Argenx Se (ARGX) and AngioDynamics (ANGO)
AngioDynamics Analyst Ratings
AngioDynamics Analyst Ratings
Buy Rating on AngioDynamics: Growth and Regulatory Approvals Underscore Positive Outlook
AngioDynamics Analyst Ratings
Buy Rating Reaffirmed for AngioDynamics Amidst Strategic Growth and Med-Tech Sector Potential
Analysts' Top Healthcare Picks: AngioDynamics (ANGO), Corcept Therapeutics (CORT)
Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $10